| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Datavault AI Inc.
13D/A
Amendment 5
DVLT · 86633R609
|
17.2% |
8/24/2026
Event 8/20/2026
|
|||
|
Semnur Pharmaceuticals, Inc.
13D/A
Amendment 2
SMNRW · 81686G113
|
78.9% |
6/26/2026
Event 6/15/2026
|
|||
| Scilex Holding Company | 78.9% | ||||
| Scilex, Inc. | 75.9% | ||||
|
Datavault AI Inc.
13D/A
Amendment 4
DVLT · 86633R609
|
37.3% |
1/14/2026
Event 1/12/2026
|
|||
|
Datavault AI Inc.
13D/A
Amendment 3
DVLT · 86633R609
|
40.1% |
1/8/2026
Event 1/6/2026
|
|||
|
Datavault AI Inc.
13D/A
Amendment 2
DVLT · 86633R609
|
42.6% |
12/31/2025
Event 12/29/2025
|
|||
|
Datavault AI Inc.
13D
DVLT · 86633R609
|
48.0% |
12/1/2025
Event 10/23/2025
|
|||
|
Semnur Pharmaceuticals, Inc.
13D/A
Amendment 1
SMNRW · 81686G113
|
82.1% |
10/14/2025
Event 9/22/2025
|
|||
| Scilex Holding Company | 82.1% | ||||
| Scilex, Inc. | 79.1% | ||||
|
Datavault AI Inc.
13D
DVLT · 86633R609
|
8.0% |
10/2/2025
Event 9/25/2025
|
|||
|
Semnur Pharmaceuticals, Inc.
13D
SMNRW · 81686G113
|
79.9% |
9/26/2025
Event 9/22/2025
|
|||
| Scilex Holding Company | 79.9% | ||||
| Scilex, Inc. | 77.0% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.